In 2000, Ohki et al. [6] identified a new gene called Reprimo (latin for repress), a potential new gene p53-dependent tumor suppressor by using differential display polymerase chain reaction (PCR) in x-ray-irradiated mouse embryonic fibroblasts. Here, TP53 is linked to neoplasm.